What is the preferred term for Idiopathic (IIH) Intracranial Hypertension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Preferred Term for Idiopathic Intracranial Hypertension (IIH)

The preferred term for this condition is "Idiopathic Intracranial Hypertension (IIH)" as established by consensus guidelines from the Journal of Neurology, Neurosurgery and Psychiatry. 1

Rationale for Current Terminology

The term "Idiopathic Intracranial Hypertension" has been formally established through:

  • Consensus guidelines developed by a specialist interest group including neurology, neurosurgery, neuroradiology, ophthalmology, nursing, primary care doctors and patient representatives 1
  • Endorsement by multiple professional bodies including the Association of British Neurologists, British Association for the Study of Headache, the Society of British Neurological Surgeons and the Royal College of Ophthalmologists 1
  • Consistent use in contemporary medical literature and diagnostic criteria 2

Historical Context and Terminology Evolution

The condition has been known by various names over time:

  • "Pseudotumor cerebri" (older term still occasionally used) 3
  • "Benign intracranial hypertension" (outdated term)

The shift away from these older terms reflects improved understanding of the condition's potential serious consequences, particularly regarding vision loss. The term "benign" was abandoned as it incorrectly suggested the condition was harmless, when in fact it can lead to permanent visual impairment if not properly managed 1, 2.

Subtypes and Classification

Current guidelines recognize several subtypes of IIH that should be specified when discussing the condition 1, 2:

  • Typical IIH: Female, reproductive age, BMI >30 kg/m²
  • Atypical IIH: Not meeting typical criteria (not female, not of reproductive age, or BMI <30 kg/m²)
  • Fulminant IIH: Rapid visual decline within 4 weeks of diagnosis
  • IIH without papilledema (IIHWOP): Meets all criteria except for papilledema
  • IIH in ocular remission: Previously diagnosed IIH where papilledema has resolved

Diagnostic Criteria

The diagnosis of IIH requires all of the following 1, 2:

  • Papilledema
  • Normal neurological examination (except for possible sixth nerve palsy)
  • Normal brain parenchyma on neuroimaging
  • Normal CSF composition
  • Elevated lumbar puncture opening pressure (>250 mm H₂O in adults)

Clinical Implications of Terminology

Using the correct terminology is important for:

  1. Accurate communication between healthcare providers
  2. Proper documentation in medical records
  3. Appropriate patient education about the potential seriousness of the condition
  4. Consistency in research and clinical trials

Conclusion

The term "Idiopathic Intracranial Hypertension (IIH)" should be used when referring to this condition, with appropriate subtype specification when applicable. This terminology accurately reflects the pathophysiology (increased intracranial pressure) while acknowledging that the underlying cause remains unknown (idiopathic) in most cases.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Idiopathic Intracranial Hypertension (IIH) Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.